Clearside Biomedical Inc (CLSD)
1.44
+0.11
(+8.27%)
USD |
NASDAQ |
Oct 04, 16:00
1.44
0.00 (0.00%)
After-Hours: 20:00
Clearside Biomedical Shareholders Equity (Annual): -15.91M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -15.91M |
| December 31, 2022 | 10.61M |
| December 31, 2021 | 37.98M |
| December 31, 2020 | 8.763M |
| December 31, 2019 | 11.16M |
| December 31, 2018 | 23.62M |
| Date | Value |
|---|---|
| December 31, 2017 | 21.42M |
| December 31, 2016 | 71.66M |
| December 31, 2015 | -36.66M |
| December 31, 2014 | -19.21M |
| December 31, 2013 | -10.74M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-15.91M
Minimum
2023
37.98M
Maximum
2021
10.52M
Average
10.61M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Arcus Biosciences Inc | 462.00M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 39.70M |